Scintigraphic Assessment of Patients with Electrocardiographic Left Ventricular Hypertrophy with ST-T Changes Without Apparent Cause

Clinical Nuclear Medicine

Volumn 27, Issue 9, 2002, Pages 641-647

  Narita, Michihiro ^a,b   Kurihara, Tadashi ^a  

^a SUMITOMO HOSPITAL   (Japan)

^b Sumitomo Building Clinic   (Japan)

Author keywords

Apical Defect; Electrocardiography; I 123 Metaiodobenzylguanidine; Left Ventricular Hypertrophy

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; 15 (4 IODOPHENYL) 3 METHYLPENTADECANOIC ACID I 123; FATTY ACID; (3 IODOBENZYL)GUANIDINE; DIAGNOSTIC AGENT; IODOBENZENE; IODOFILTIC ACID; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; EXERCISE TEST; FATTY ACID METABOLISM; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE BIOPSY; HEART PERFUSION; HEART SCINTISCANNING; HEART VENTRICULOGRAPHY; HUMAN; HUMAN TISSUE; HYPERTROPHIC CARDIOMYOPATHY; MALE; PERFUSION; ST SEGMENT; ANGIOCARDIOGRAPHY; BIOPSY; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; ELECTROCARDIOGRAPHY; HEART; HEART MUSCLE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; RADIOISOTOPE VENTRICULOGRAPHY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

3-IODOBENZYLGUANIDINE; BIOPSY; CORONARY ANGIOGRAPHY; ELECTROCARDIOGRAPHY; EXERCISE TEST; FATTY ACIDS; FEMALE; FOLLOW-UP STUDIES; HEART; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; IODOBENZENES; MALE; MIDDLE AGED; MYOCARDIUM; RADIONUCLIDE VENTRICULOGRAPHY; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0036730441     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-200209000-00007     Document Type: Article

References (32)

1. Fisch C: Electrocardiography and vectorcardiography. In: Braunwald E, ed. Heart Disease: A Textbook of Cardiovascular Medicine, 4th ed. Philadelphia: WB Saunders, 1992, pp 116-79.
2. Noda A, Yagi T, Yamada H, et al: Electrocardiographic diagnosis of left ventricular hypertrophy improved by considering both QRS voltage and ST-T criteria. Jpn Cir J 58:698, 1994.
3. Devereux RB, Reichek N: Repolarization abnormalities of left ventricular hypertrophy. Clinical, echocardiographic and hemodynamic correlates. J Elecrocardiol 15:47, 1982.
4. Yamaguchi H, Ishimura T, Nishiyama S, et al: Hypertrophic non-obstructive cardiomyopathy with giant negative T waves (apical hypertrophy): ventriculographic and echocardiographic features in 30 patients. Am J Cardiol 44:401, 1979.
5. Maron BJ: Apical Apical hypertrophic cardiomyopathy: the continuing saga. J Am Coll Cardiol 15:91, 1990.
6. Fujii J, Saihara S, Sawada H, et al: Distribution of left ventricular hypertrophy and electrocardiographic findings in patients with so-called apical hypertrophic cardiomyopathy. J Cardiol 15(suppl VI):VI23, 1985.
7. Kurata C, Tawarahara K, Taguchi T, et al: Myocardial emission computed tomography with iodine-123-labeled beta-methyl-branched fatty acid in patients with hypertrophic cardiomyopathy. J Nucl Med 33:6, 1992.
8. Matuo S, Nakamura Y, Takahashi M, et al: Myocardial metabolic abnormalities in hypertrophic cardiomyopathy assessed by iodine-123-labeled beta-methyl-branched fatty acid myocardial scintigraphy and its relation to exercise-induced ischemia. Jpn Circ J 62:167, 1996.
9. 201T1 scintigraphy. Kokyu to Junkan 41:1089, 1993.
10. Lefroy DC, De Silva R, Choudhury L: Diffuse reduction of myocardial beta-adreno-receptors in hypertrophic cardiomyopathy: a study with positron emission tomography. J Am Coll Cardiol 22:1653, 1993.
11. Berman DS, Kiat HS, Van Train KF, et al: Myocardial perfusion imaging with technetium-99m-sestamibi: comparative analysis of available imaging protocols. J Nucl Med 35:681, 1994.
12. Hoe J, Powers J, Iskandrian AE: Exercise-rest same-day SPECT sestamibi imaging to detect coronary artery disease. J Nucl Med 38:200, 1997.
13. 123I-BMIPP imaging in patients with myocardial infarction. Kakuigaku 34:177, 1997.
14. Narita M, Kurihara T, Shindoh T, et al: Characteristics of myocardial ischemia in patients with chronic renal failure and its relation to cardiac sympathetic activity. Kakuigaku 36:979, 1999.
15. Narita M, Kurihara T: Evaluation of long-term prognosis in patients with heart failure. Is cardiac imaging with Iodine-123 metaiodo-benzylguanidine useful? J Cardiol 31:343, 1998.
16. Narita M, Kurihara T. Fatty acid metabolism in patients with idiopathic dilated cardiomyopathy: characteristics and prognostic implications. J Cardiol 25:223, 1995.
17. Sahn DJ, DeMaria A, Kisslo J, et al: Recommendation regarding quantitation in M-mode echocardiography: result of a survey of echocardiographic measurements. Circulation 44:1072, 1978.
18. Gill JS, Hunter GJ, Gane D, et al: Heterogeniety of the human myocardial sympathetic innervation: In vivo demonstration by iodine-123 labeled metaiodobenzylguanidine scintigraphy. Am Heart J 126:390, 1993.
19. 123I-MIBG in normal human hearts. Kakuigaku 30:1359, 1993.
20. Nakajo M, Shimabukuro K, Yoshimura H, et al: Iodine-131 metaiodobenzylguanidine intra- and extra-vascular accumulation in the rat heart. J Nucl Med 27:84, 1986.
21. Wakasugi S, Wada A, Hasegawa Y, et al: Detection of abnormal cardiac adrenergic neuron-activity in Adriamycin-induced cardiomyopathy with iodine-123-metaiodobenzylguanidine. J Nucl Med 33:208, 1992.
22. Schofer J, Spielmann R, Schuchert A, et al: Iodine-123 metaiodobenzylguanidine scintigraphy: a non-invasive method to demonstrate myocardial adrenergic nervous system disintegrity in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 12:1252, 1998.
23. Rabinovitch MA, Rose CP, Schwab AJ, et al: A method of dynamic analysis of I-123-metaiodobenzylguanidine scintigrams in cardiac mechanical overload hypertrophy and failure. J Nucl Med 34:589, 1993.
24. Glowniak JV, Turner FE, Gray LL, et al: Iodine-131 metaiodobenzylguanidine imaging of the heart in idiopathic congestive cardiomyopathy and cardiac transplants. J Nucl Med 30:1182, 1989.
25. Maron BJ, Bonow RO, Cannon IIIRO, et al: Hypertrophic cardiomyopathy. Interrelation of clinical manifestations, pathophysiology, and therapy. N Engl J Med 316:780, 1987.
26. Shimizu M, Sugihara N, Kita Y, et al: Long term course and cardiac sympathetic nerve activity in patients with hypertrophic cardiomyopathy. Br Heart J 26:155, 1992.
27. Maron BJ, Wolfson JK, Epstein SE, et al: Intramural (small vessel) coronary artery disease in hypertrophic cardio-myopathy. J Am Coll Cardiol 8:545, 1986.
28. Crowley JJ, Dardas PS, Shapiro LM: Assessment of apical hypertrophic cardiomyopathy using transoesophageal echo-cardiography. Cardiology 88:189, 1997.
29. Gaudio C, Pelliccia F, Tanzill G, et al: Magnetic resonance imaging for assessment of apical hypertrophy in hypertrophic cardiomyopathy. Clin Cardiol 15:164, 1992.
30. Reddy V, Korcarz C, Weinert L, et al: Apical hypertrophic cardiomyopathy. Circulation 98:2354, 1998.
31. Kozelj M, Pavcnik D, Surlan M: Apical hypertrophic cardiomyopathy. Circulation 101:e44, 2000.
32. Kozelj M, Pavcnik, Surlan M: Asymmetric hypertrophic cardiomyopathy diagnosed by echocardiography and magnetic resonance imaging. Case reports. Angiology 47:501, 1996.